Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Testosterone levels in benign prostatic hyperplasia: sexual function and response to therapy with dutasteride

Nature Clinical Practice Urology volume 3, pages 528–529 (2006)Cite this article

boxed-textMarberger M et al. (2006) Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. J Clin Endocrinol Metab 91: 1323–1328

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kaufman JM and Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26: 833–876

    Article  CAS  Google Scholar 

  2. Korenman SG et al. (1990) Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 71: 963–969

    Article  CAS  Google Scholar 

  3. Buena F et al. (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal range. Fert Steril 59: 1118–1123

    Article  CAS  Google Scholar 

  4. Bhasin S et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995–2010

    Article  CAS  Google Scholar 

  5. Liverman CT and Blazer DG (2004) Testosterone and Aging. Clinical Research Directions. Washington, DC: The National Academy Press

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. Professor of Medicine and the Chief of Endocrinology at Harbor–UCLA Medical Center in the David Geffen School of Medicine at UCLA and LA Biomedical Research Institute, Torrance, CA, USA

    Ronald Swerdloff

Authors
  1. Ronald Swerdloff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald Swerdloff.

Ethics declarations

Competing interests

Dr Swerdloff has declared the following associations:

Besins/Ascend – Investigator, Research Support

Clarus – Investigator, Research Support

Corcept – Consultant

Glaxo SmithKline – Advisory Board member

Organon – Investigator, Research Support

Solvay Pharmaceuticals, Inc Company – Speaker, Advisory Board member, Investigator, Research Support

Zonagen – Investigator, Research Support

Dr Swerdloff is not a stockholder or owner of any of these companies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swerdloff, R. Testosterone levels in benign prostatic hyperplasia: sexual function and response to therapy with dutasteride. Nat Rev Urol 3, 528–529 (2006). https://doi.org/10.1038/ncpuro0600

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0600

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing